Authorized Representative (AR) in Turkey for Medical Devices: Scope, Fees, and Compliance Strategy (2026 Guide)
Authorized Representative (AR) in Turkey for Medical Devices: Scope, Fees, and Compliance Strategy (2026 Guide)

Search for a command to run...
Authorized Representative (AR) in Turkey for Medical Devices: Scope, Fees, and Compliance Strategy (2026 Guide)

No comments yet. Be the first to comment.
Online Eğitim ve Zoom Gelirlerinde %15 Vergi: 2026 Tarihli 20/B Özelgesi

Türkiye’de Yaşayanların Yurt Dışı Airbnb Geliri Nasıl Vergilendirilir?

Sosyal Medya ve Dijital Gelirlerde Vergi İstisnası: 2026 Tarihli Yeni Özelge 20/B’nin Sınırlarını Netleştirdi

2026 Birden Fazla İşverenden Ücret Alanlar: 400.000 TL ve 5.300.000 TL Beyan Sınırı

Türkiye’den İtalya’ya Taşınanlar İçin Vergi Planlaması: Yabancı Hisse Senetleri, ABD Borsası ve Sermaye Kazançları

Appointing an Authorized Representative (AR) in Turkey is mandatory for foreign medical device manufacturers. Learn the scope, legal obligations, costs, and whether standalone AR services are feasible.
authorized-representative-turkey-medical-devices
Foreign medical device manufacturers must appoint a local Authorized Representative (AR) to access the Turkish market
The AR role carries legal and regulatory liability—not just administrative representation
Standalone AR services are technically possible but often risky without regulatory support
Annual AR fees vary depending on device classification, portfolio size, and risk exposure
Improper AR structuring can lead to administrative penalties, product suspension, or recalls
For non-resident medical device manufacturers, appointing a local Authorized Representative (AR) is not optional—it is a regulatory requirement.
Turkey operates under a framework aligned with EU regulations, including:
MDR (Medical Device Regulation)
IVDR (In Vitro Diagnostic Regulation)
Oversight by the Turkish Medicines and Medical Devices Agency (TİTCK)
Additionally, all devices must be registered in the national tracking system (ÜTS – Product Tracking System).
Key takeaway: Without a locally appointed AR, you cannot legally place medical devices on the Turkish market.
The AR is not merely a formal contact point. The role includes substantial operational and legal responsibilities.
Acting as the official representative of the manufacturer in Turkey
Managing ÜTS (Product Tracking System) registrations
Maintaining technical documentation and declarations of conformity
Acting as the primary contact for TİTCK
Managing post-market surveillance and vigilance processes
Supporting inspections and regulatory audits
In certain scenarios, the AR may share liability with the manufacturer, particularly in cases of:
Non-compliant products
Incomplete or inaccurate documentation
Failure to meet regulatory obligations
This makes AR selection a risk management decision, not just a compliance checkbox.
This is one of the most common questions from international manufacturers.
You can appoint an AR without engaging in broader regulatory consulting
Services can be contractually separated
Because:
ÜTS registration requires technical accuracy
Device classification errors are common
Technical file gaps may create liability for both the manufacturer and AR
Most experienced providers:
Offer AR services bundled with compliance support
Or require minimum regulatory validation before accepting the mandate
Conclusion: Standalone AR services are feasible but only recommended for manufacturers with strong in-house regulatory expertise.
There is no fixed pricing model. Fees depend on several variables.
Device classification (Class I, IIa, IIb, III)
Number of products
Risk profile
Scope of documentation
Additional services (audit support, vigilance, regulatory consulting)
| Service Level | Annual Fee Range |
|---|---|
| Basic AR (Class I, low risk) | €1,500 – €3,000 |
| Mid-level (Class IIa / IIb) | €3,000 – €7,000 |
| High-risk (Class III) | €7,000 – €15,000+ |
| Additional regulatory services | Quoted separately |
Note: Larger product portfolios or complex regulatory structures significantly increase fees.
→ It carries legal accountability
→ Increases audit and compliance risks
→ Errors can block market access
→ Leads to inconsistencies and exposure
There are two main approaches when entering the Turkish market:
Lower cost
Higher compliance risk
Requires strong internal regulatory team
Higher cost
Significantly reduced risk
Faster and smoother market entry
Most international manufacturers prefer the second model to mitigate regulatory exposure.
Yes, for all non-resident manufacturers.
Yes, but the transition must be carefully managed, especially within ÜTS.
Typically between 1 to 3 weeks.
No. An AR allows market entry without local incorporation.
Turkey represents a high-growth medical device market, but it is also highly regulated and enforcement-driven.
Your Authorized Representative will directly impact:
Market access
Regulatory risk exposure
Long-term operational sustainability
Positioning AR services purely as a cost item is a common but critical mistake. In reality, it is a strategic compliance investment.
If you are considering entering the Turkish medical device market and require a reliable Authorized Representative—whether as a standalone service or fully integrated with regulatory compliance—we can structure a solution tailored to your product portfolio and risk profile.
Contact us to receive a detailed proposal including scope, timeline, and annual fee structure.